Evidence map›Paper›PMID 32316332›Full record

ArticleInternational journal of molecular sciences2020

"Mitotic Slippage" and Extranuclear DNA in Cancer Chemoresistance: A Focus on Telomeres.

Kristine Salmina, Agnieszka Bojko, Inna Inashkina, Karolina Staniak, Magdalena Dudkowska, Petar Podlesniy, Felikss Rumnieks, Ninel M Vainshelbaum, Dace Pjanova, Ewa Sikora and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. CCDC68 Maintains Mitotic Checkpoint Activation by Promoting CDC20 Integration into the MCC.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  6. Special Issue "Advances in Genome Regulation in Cancer".International journal of molecular sciences · 2023
    Article
  7. Review
  8. Article
  9. Article
  10. Spatial-Temporal Genome Regulation in Stress-Response and Cell-Fate Change.International journal of molecular sciences · 2023
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Necroptosis as a Novel Facet of Mitotic Catastrophe.International journal of molecular sciences · 2022
    Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Kristine SalminaCancer Research Division, Latvian Biomedicine Research and Study Centre, LV-1067 Riga, Latvia.
Agnieszka BojkoNencki Institute of Experimental Biology, Polish Academy of Sciences, 3 Pasteura St., 02-093 Warsaw, Poland.ORCID 0000-0002-8680-3300
Inna InashkinaCancer Research Division, Latvian Biomedicine Research and Study Centre, LV-1067 Riga, Latvia.
Karolina StaniakNencki Institute of Experimental Biology, Polish Academy of Sciences, 3 Pasteura St., 02-093 Warsaw, Poland.
Magdalena DudkowskaNencki Institute of Experimental Biology, Polish Academy of Sciences, 3 Pasteura St., 02-093 Warsaw, Poland.
Petar PodlesniyCiberNed (Centro Investigacion Biomedica en Red Enfermedades Neurodegenerativas), IIBB, Rosello 161, 08036 Barcelona, Spain.
Felikss RumnieksCancer Research Division, Latvian Biomedicine Research and Study Centre, LV-1067 Riga, Latvia.
Ninel M VainshelbaumCancer Research Division, Latvian Biomedicine Research and Study Centre, LV-1067 Riga, Latvia.
Dace PjanovaCancer Research Division, Latvian Biomedicine Research and Study Centre, LV-1067 Riga, Latvia.
Ewa SikoraNencki Institute of Experimental Biology, Polish Academy of Sciences, 3 Pasteura St., 02-093 Warsaw, Poland.
Jekaterina ErenpreisaCancer Research Division, Latvian Biomedicine Research and Study Centre, LV-1067 Riga, Latvia.ORCID 0000-0002-2870-7775
Latvian Biomedical Research and Study Centre · LVInstytut Biologii Doświadczalnej im. Marcelego Nenckiego · PLBiomedical Research Networking Center on Neurodegenerative Diseases · ES

Funding

European Regional Development Fund 1.1.1.2/VIAA/3/19/463Latvijas Universitātes Fonds PhD Student ScholarshipMinisterio de Ciencia e Innovación SAF2017-89791-RPolska Akademia Nauk UMO-2015/17/B/NZ3/03531
6 · The paper itself

Abstract

Mitotic slippage (MS), the incomplete mitosis that results in a doubled genome in interphase, is a typical response of

Indexed as

Antibiotics, AntineoplasticCell Cycle CheckpointsCell Line, TumorCell ProliferationCellular SenescenceDNADNA DamageDoxorubicinDrug Resistance, NeoplasmHumansMitosisNeoplasmsRecombinational DNA RepairSequestosome-1 ProteinTelomeraseTelomereAntibiotics, AntineoplasticDNADoxorubicinSequestosome-1 ProteinSQSTM1 protein, humanTelomeraseTelomeric Repeat Binding Protein 2ALTamoeboid conversionbudding of mitotic progenycellular senescenceextranuclear DNAgenotoxic treatmentinverted meiosismtTP53 cancerpolyploidizationSQSTM1/p62

Identifiers

PMID32316332
PMCPMC7215480
OpenAlexW3016853940

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.